Wednesday, July 06, 2005
Stem cells
StemCells, Inc. announced today that it has entered into an agreement with ReNeuron, a privately-owned UK biotech corporation. The agreement enables ReNeuron to exploit its "c-mycER" conditionally immortalized adult human neural stem cell technology for therapy and other purposes.
In return for the license, StemCells received an equity interest in ReNeuron and a cross-license to the exclusive use of ReNeuron's technology for certain diseases and conditions, including lysosomal storage diseases, spinal cord injury, cerebral palsy and multiple sclerosis. ReNeuron will supply cells for StemCells use under the cross-license.
Hmm. That's funny. I thought the only stem cells worth using are embryonic cells, and I thought that Bushitler had prohibited all stem cell research. Must have misread something. Or maybe the media are deliberately misreporting... Nah.
Seriously, this is exciting news. I need to learn more on this subject; "conditionally immortalized" is just too tantalizing to skip over.
Story here ¶ 8:49 AM
In return for the license, StemCells received an equity interest in ReNeuron and a cross-license to the exclusive use of ReNeuron's technology for certain diseases and conditions, including lysosomal storage diseases, spinal cord injury, cerebral palsy and multiple sclerosis. ReNeuron will supply cells for StemCells use under the cross-license.
Hmm. That's funny. I thought the only stem cells worth using are embryonic cells, and I thought that Bushitler had prohibited all stem cell research. Must have misread something. Or maybe the media are deliberately misreporting... Nah.
Seriously, this is exciting news. I need to learn more on this subject; "conditionally immortalized" is just too tantalizing to skip over.
Story here ¶ 8:49 AM
